Slow progress in malaria vaccine development.
Dove
A
A
D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D017780:Malaria Vaccines; D020066:Merozoite Surface Protein 1; D051379:Mice; D008822:Mice, Transgenic; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*; D011498:Protein Precursors / Q000235:genetics / Q000276:immunology; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology; D014944:World Health Organization
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D020066:Merozoite Surface Protein 1; D011498:Protein Precursors; D015800:Protozoan Proteins